Clinical trials: Transplant Failure
Aplastic Anaemia
Conditioning Regimen Containing Low-Dose ATG for the Treatment of AA Receiving sUCBT
To evaluate the safety and efficacy of Single Umbilical Cord blood transplantation (sUCBT) containing low dose ATG based conditioning regimen in the treatment of Aplastic Anemia (AA)
- Trial name
- NCT07885982
- Testing
- Anti-Thymocyte Globulin (Rabbit) (Thymoglobulin®)
- Where
- China
- Volunteers
- 59 people
- Sponsor
- Anhui Provincial Hospital
Kidney Donation, Kidney Failure
Live Kidney Donor Study -Renal Function Study
Kidney transplantation from living donors has been shown to carry many benefits over deceased donor transplantation. Because of benefits such as shorter waiting times and improved outcome for transplant recipients, living kidney…
- Conditions
- Kidney Donation, Kidney Failure, Kidney Transplantation
- Trial name
- NCT01158742
- Testing
- Glomerular Filtration Rate with Iothalamate, Glomerular Filtration Rate with Iohexol
- Where
- 3 sites in United States
- Volunteers
- 402 people
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
Disorders Related to Lung Transplantation, Graft Failure
EVLP to Evaluate the Eligibility for Transplantation of DCD-Lungs
The procurement of organs from donors after cardiocirculatory death (DCD) is an accepted strategy to increase organ supply.
- Trial name
- EVLP-DCD (NCT02061462)
- Testing
- EVLP-DCD Group
- Where
- Italy
- Volunteers
- 10 people
- Sponsor
- Policlinico Hospital
Kidney Failure, Chronic, End-Stage Renal Disease
Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant
Patients who have had a previous allograft failure represent a major problem for transplant centers as they are highly-human leukocyte antigen (HLA) sensitized and unlikely to receive another transplant without significant…
- Conditions
- Kidney Failure, Chronic, End-Stage Renal Disease, Transplant Glomerulopathy, Transplant;Failure,Kidney
- Trial name
- NCT03380962
- Testing
- Clazakizumab
- Where
- United States
- Volunteers
- 20 people
- Sponsor
- Stanley Jordan, MD
Kidney Transplant; Complications, Kidney Diseases
Dietary Intervention to Improve Kidney Transplant Outcomes
Randomized controlled trial of a curriculum intervention teaching patients to eat a whole-food plant-based dietary pattern versus standard of care in kidney transplant recipients within the first few months of transplant
- Conditions
- Kidney Transplant; Complications, Kidney Diseases, Transplant;Failure,Kidney, Diabetes
- Trial name
- NCT05449496
- Testing
- Dietary Education Curriculum
- Where
- United States
- Volunteers
- 49 people
- Sponsor
- University of California, Davis
Liver Transplantation
Assessment of a Quantra-guided Transfusion Algorithm in Liver Transplantation
Liver transplantation carries a substantial risk of bleeding, making precise haemostasis control essential, although assessing coagulation remains challenging.
- Trial name
- QUALIVERT (NCT06749405)
- Testing
- Transfusion algorithm based on Quantra®, Conventional transfusion algorithm
- Where
- France
- Volunteers
- 56 people
- Sponsor
- University Hospital, Toulouse
Cardiac Rehabilitation, Heart Failure
Cardiac REhabilitation COhort at the Medicine Campus DaVos to invEstigate Recovery
The RECOVER study, titled Cardiac Rehabilitation Cohort at the Medicine Campus Davos for Exploration of Recovery, is a prospective, non-interventional, monocentric cohort study conducted at the Hochgebirgsklinik Davos.
- Conditions
- Cardiac Rehabilitation, Heart Failure, Cardiac Arrest (CA), ACS (Acute Coronary Syndrome)
- Trial name
- RECOVER (NCT07096973)
- Where
- Switzerland
- Volunteers
- 10,000 people
- Sponsor
- Hochgebirgsklinik Davos
End Stage Liver DIsease, Liver Failure
VitaSmart HOPE System: Bridge to HOPE Registry
This is a post-market, multicenter, single-arm, observational registry evaluating real-world use of the VitaSmart HOPE System under standard of care conditions.
- Trial name
- NCT07578441
- Testing
- hypothermic oxygenated perfusion therapy of a donor liver under standard of care conditions
- Where
- United States
- Volunteers
- 5,000 people
- Sponsor
- Bridge to Life Ltd.
Kidney Allograft Fibrosis, Kidney Transplant Failure and Rejection
Urinary Transglutaminase 2 as a Biomarker for Kidney Allograft Fibrosis
The aim of this study is to verify the ability of transglutaminase type 2 to predict rejection or chronic allograft nephropathy of renal allograft.
- Trial name
- NCT03487861
- Testing
- observational(urinary biomarker for kidney allograft fibrosis)
- Where
- South Korea
- Volunteers
- 1,000 people
- Sponsor
- Asan Medical Center
Blood Stem Cell Transplant Failure
Analysis of Biomarkers for Acute Graft-versus-Host Disease (GVHD)
Samples of blood and urine will be analyzed for biomarkers to check their predictivity of Graft-versus-Host Disease (GVHD) outcomes.
- Trial name
- NCT01569373
- Where
- United States
- Sponsor
- Mayo Clinic
Chronic Myeloproliferative Disorders, Leukemia
Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone
RATIONALE: Gathering information about how often methemoglobinemia occurs in young patients receiving dapsone for hematologic cancer or aplastic anemia may help doctors learn more about the disease and plan the best treatment.
- Conditions
- Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Lymphoproliferative Disorder
- Trial name
- NCT00993694
- Testing
- chemotherapy, dapsone, medical chart review
- Where
- 2 sites in United States
- Volunteers
- 41 people
- Sponsor
- Vanderbilt University
Renal Failure, Medication Adherence
Adherence Enhancement for Renal Transplant Patients
Despite significant advances in the care of kidney transplant recipients, long term graft survival after renal transplantation remains suboptimal. Medication nonadherence and clinical inertia are key contributors to graft loss.
- Conditions
- Renal Failure, Medication Adherence, Hypertension
- Trial name
- NCT01859273
- Testing
- mHealth
- Where
- United States
- Volunteers
- 18 people
- Sponsor
- Medical University of South Carolina
Transplant;Failure,Kidney, Transplant; Failure, Pancreas
Eliminating the Need for Pancreas Biopsy Using Peripheral Blood Cell-free DNA
Donor-derived cell-free DNA (dd-cfDNA) has shown promise as an early marker for cellular injury caused by rejection. dd-cfDNA changes may also indicate other injuries that lead to progressive decline in transplant organ function…
- Conditions
- Transplant;Failure,Kidney, Transplant; Failure, Pancreas, Rejection Acute Renal, Rejection Acute Pancreas
- Trial name
- PancDX (NCT04166149)
- Testing
- dd-cfDNA Blood Test
- Where
- 3 sites in United States
- Volunteers
- 140 people
- Sponsor
- University of Maryland, Baltimore
Chronic Heart Failure
Snapshot Evaluation of Acute and Chronic Heart Failure in Real Life in Turkey
This study, which will be conducted at 23 sites representing the determined NUTS-1 regions in Turkey, in which all patients who were admitted to clinic or were hospitalized with Heart Failure (Acute or Chronic) diagnosis will be…
- Trial name
- SELFIE-TR (NCT02578225)
- Testing
- Non interventional study
- Where
- 23 sites in Turkey (Türkiye)
- Volunteers
- 1,054 people
- Sponsor
- Prof. Dr. Mehmet Birhan Yılmaz
Transplant; Failure, Kidney
Desensitization Protocol for Deceased Donor List
Purpose of the study: The specific aims of this study are to evaluate overall efficacy and safety of the pre-transplant IVIG treatment in our transplant center since 2007 and to identify factors affecting treatment outcomes in…
- Trial name
- NCT01642225
- Where
- United States
- Volunteers
- 180 people
- Sponsor
- University of Miami
Aplastic Anemias, Hemoglobinopathies
The HOPE Biobank Resource (BMT CTN 2402 HOPE)
A prospective, multicenter study that will establish a repository of biospecimens and clinical data from patients undergoing hematopoietic stem cell transplant (HCT) or gene therapy (GT) for treatment of non-malignant blood…
- Conditions
- Aplastic Anemias, Hemoglobinopathies, Bone Marrow Failure
- Trial name
- HOPE Resource (NCT07227155)
- Where
- 14 sites in United States
- Volunteers
- 375 people, healthy volunteers welcome
- Sponsor
- Medical College of Wisconsin
Refractory Idiopathic Aplastic Anemia, Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide in Patients With Acquired Refractory Aplastic Anemia or in Relapse After Immunosuppression
Outcomes for patients with severe aplastic anemia (SAA) who are refractory to first-line immunosuppressive therapy (IST) and who lack a matched unrelated donor (MUD) remain poor.
- Trial name
- HAPLO-EMPTY (NCT05126849)
- Testing
- Allogenic transplantation
- Where
- 35 sites in France
- Volunteers
- 31 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Liver Transplant Failure
Plasmatic Factor V as a Predictor of Graft Dysfunction After Liver Transplantation
Factor V is a coagulation cofactor that is primarily produced by the liver. Previous data has suggested a correlation between factor V levels and graft dysfunction.
- Trial name
- NCT03396016
- Where
- Canada
- Volunteers
- 140 people
- Sponsor
- University Health Network, Toronto
Liver Transplantation
Correlation Between Release of Cytokines From Liver Graft and Hemodynamic Instability
The primary goal of this project is to identify the source of cytokines that are released into circulation during graft reperfusion. Seventeen patients scheduled to have adult cadaveric liver transplantation at the Milton S.
- Trial name
- NCT01120743
- Where
- United States
- Volunteers
- 17 people
- Sponsor
- Penn State University
Allogeneic Disease, GVHD,Acute
Wharton Jelly Mesenchymal Stromal Cells as GVHD Prophylaxis
Despite progress in chemotherapy, targeted therapy and immunotherapy, allogeneic hematopoietic stem cell transplantation (allo-SCT) is still the only curative procedure for some hematological malignancies.
- Conditions
- Allogeneic Disease, GVHD,Acute, Graft Failure
- Trial name
- HAPLO-GEL (NCT05855707)
- Testing
- WJ-MSC infusion
- Volunteers
- 12 people
- Sponsor
- Central Hospital, Nancy, France